Ligand Pharmaceuticals Inc
F:LGDN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Ligand Pharmaceuticals Inc
F:LGDN
|
US |
|
Tiger Brands Ltd
OTC:TBLMF
|
ZA |
|
A
|
Abbvie Inc
SWB:4AB
|
US |
|
A
|
Air Products and Chemicals Inc
SWB:AP3
|
US |
|
A
|
Arcelormittal South Africa Ltd
XMUN:ISC1
|
ZA |
|
NextNav Inc
F:KK0
|
US |
|
C
|
China Oilfield Services Ltd
XMUN:CO9
|
CN |
|
Rexford Industrial Realty Inc
NYSE:REXR
|
US |
|
S
|
Spectral Medical Inc
OTC:EDTXF
|
CA |
|
C
|
China Merchants Port Holdings Co Ltd
F:CPM
|
HK |
|
I
|
Inpixon
F:1XS4
|
US |
|
H
|
Harmony Gold Mining Company Ltd
SWB:HAM1
|
ZA |
|
F
|
FirstGroup PLC
F:FGR
|
UK |
|
M
|
Mitsubishi Heavy Industries Ltd
XMUN:MIH
|
JP |
|
S
|
Spire Inc
F:LGR
|
US |
|
B
|
Bureau Veritas SA
DUS:4BV
|
FR |
|
D
|
Deluxe Corp
XMUN:DL8
|
US |
|
G
|
Grand Baoxin Auto Group Ltd
F:6BA
|
CN |
|
Grifols SA
OTC:GIKLY
|
ES |
|
Aligos Therapeutics Inc
F:5WK
|
US |
|
Stellantis NV
PAR:STLAP
|
NL |
|
Hyundai Motor Co
KRX:005380
|
KR |
|
O
|
Old Second Bancorp Inc
XBER:OSB
|
US |
Wall St Price Targets
LGDN Price Targets Summary
Ligand Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for LGDN is 163.59 EUR with a low forecast of 144.45 EUR and a high forecast of 192.49 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LGDN's stock price target?
Price Target
163.59
EUR
According to Wall Street analysts, the average 1-year price target for LGDN is 163.59 EUR with a low forecast of 144.45 EUR and a high forecast of 192.49 EUR.
What is the Revenue forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
13%
Over the last 14 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 13%.
What is the Operating Income forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
29%
Over the last 14 years, the compound annual growth rate for Operating Income has been 26%. The projected CAGR for the next 8 years is 29%.
What is the Net Income forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
17%
Over the last 14 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 7 years is 17%.
